Nant had good reason to invest in Benitec's very promising "silence and replace" gene delivery technique our impressive team that
it has gathered around it.
Car-t gene therapy on the other hand has had its setbacks in its ongoing development
Oh, what could have been, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
